-
of pre-clinical models, and we integrate molecular and pharmacological data to develop new precision cancer medicine strategies. The Kuijjer group was established in 2018 and focuses on developing
-
the telomerase pathway is a promising strategy for cancer treatment, to date, no pharmacological options for disrupting oncogenic telomerase activity have been approved for regulatory use, despite significant
-
21st April 2024 Languages English English English Institute of Clinical medicine, Division of Laboratory medicine, Department of Microbiology PhD Research Fellow in DNA repair and telomere stability
-
try again. 21st April 2024 Languages English English English Institute of Clinical medicine, Division of Laboratory medicine, Department of Microbiology PhD Research Fellow in DNA repair and telomere
-
a platform for drug screening of pre-clinical models, and we integrate molecular and pharmacological data to develop new precision cancer medicine strategies. The Kuijjer group was established in 2018
-
genetic, pharmacological, biochemical, and genome-wide approaches such as immunohistochemistry, Chromatin Immunoprecipitation (ChIP-Seq), gene knockdown, immunoprecipitation, CRISPR-Cas9, drug screens